Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$320,178
+$34,966 QoQ
Shares Held
2,612
-3.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#242
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $12,227,346 across 14 Biotechnology names. PTGX ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,927 | $5,427,768 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
24,401 | $1,909,866 | |
| 3 | TECH |
BIO-TECHNE Corp
|
13,021 | $919,933 | |
| 4 | CYTK |
Cytokinetics Inc
|
9,887 | $842,273 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
11,380 | $651,163 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
33,083 | $594,501 | |
| 7 | MRNA |
Moderna, Inc.
|
6,604 | $462,478 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
1,152 | $428,163 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $320,178 | 2,612 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $285,212 | 2,706 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $243,154 | 2,784 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||